Correlation Between Foghorn Therapeutics and Anebulo Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Foghorn Therapeutics and Anebulo Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Foghorn Therapeutics and Anebulo Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Foghorn Therapeutics and Anebulo Pharmaceuticals, you can compare the effects of market volatilities on Foghorn Therapeutics and Anebulo Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Foghorn Therapeutics with a short position of Anebulo Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Foghorn Therapeutics and Anebulo Pharmaceuticals.
Diversification Opportunities for Foghorn Therapeutics and Anebulo Pharmaceuticals
0.36 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Foghorn and Anebulo is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Foghorn Therapeutics and Anebulo Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Anebulo Pharmaceuticals and Foghorn Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Foghorn Therapeutics are associated (or correlated) with Anebulo Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Anebulo Pharmaceuticals has no effect on the direction of Foghorn Therapeutics i.e., Foghorn Therapeutics and Anebulo Pharmaceuticals go up and down completely randomly.
Pair Corralation between Foghorn Therapeutics and Anebulo Pharmaceuticals
Given the investment horizon of 90 days Foghorn Therapeutics is expected to generate 1.12 times more return on investment than Anebulo Pharmaceuticals. However, Foghorn Therapeutics is 1.12 times more volatile than Anebulo Pharmaceuticals. It trades about 0.07 of its potential returns per unit of risk. Anebulo Pharmaceuticals is currently generating about 0.01 per unit of risk. If you would invest 349.00 in Foghorn Therapeutics on August 25, 2024 and sell it today you would earn a total of 435.00 from holding Foghorn Therapeutics or generate 124.64% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Foghorn Therapeutics vs. Anebulo Pharmaceuticals
Performance |
| Timeline |
| Foghorn Therapeutics |
| Anebulo Pharmaceuticals |
Foghorn Therapeutics and Anebulo Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Foghorn Therapeutics and Anebulo Pharmaceuticals
The main advantage of trading using opposite Foghorn Therapeutics and Anebulo Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Foghorn Therapeutics position performs unexpectedly, Anebulo Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Anebulo Pharmaceuticals will offset losses from the drop in Anebulo Pharmaceuticals' long position.| Foghorn Therapeutics vs. C4 Therapeutics | Foghorn Therapeutics vs. Prelude Therapeutics | Foghorn Therapeutics vs. Rezolute | Foghorn Therapeutics vs. Shattuck Labs |
| Anebulo Pharmaceuticals vs. Adagene | Anebulo Pharmaceuticals vs. Acrivon Therapeutics, Common | Anebulo Pharmaceuticals vs. AnaptysBio | Anebulo Pharmaceuticals vs. Mineralys Therapeutics, Common |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Complementary Tools
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |